Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.

Show other versions (1)

BACKGROUND: Strontium ranelate is currently used for osteoporosis. The international, double-blind, randomised, placebo-controlled Strontium ranelate Efficacy in Knee OsteoarthrItis triAl evaluated its effect on radiological progression of knee osteoarthritis. METHODS: Patients with knee osteoarthri...

Bibliografske podrobnosti
Main Authors:	Reginster, J, Badurski, J, Bellamy, N, Bensen, W, Chapurlat, R, Chevalier, X, Christiansen, C, Genant, H, Navarro, F, Nasonov, E, Sambrook, P, Spector, T, Cooper, C
Format:	Journal article
Jezik:	English
Izdano:	2013

Podobne knjige/članki

STRUCTURE MODIFYING EFFECTS OF STRONTIUM RANELATE IN KNEE OSTEOARTHRITIS
od: Reginster, J, et al.
Izdano: (2012)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial
od: Reginster, J, et al.
Izdano: (2012)

EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL
od: Reginster, J, et al.
Izdano: (2011)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
od: Cooper, C, et al.
Izdano: (2012)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
od: Jean-Yves Reginster, et al.
Izdano: (2014-02-01)

Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy.
od: Reginster, J, et al.
Izdano: (2012)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
od: Cyrus Cooper, et al.
Izdano: (2013-12-01)

STRONTIUM RANELATE REDUCES THE NUMBER OF RADIOLOGICAL OR RADIOCLINICAL PROGRESSORS IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS
od: Reginster, J, et al.
Izdano: (2012)

Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
od: Reginster, J, et al.
Izdano: (2012)

EFFECT OF STRONTIUM RANELATE ON KNEE PAIN IN OSTEOARTHRITIS: A RESPONDER ANALYSIS
od: Cooper, C, et al.
Izdano: (2013)

Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
od: Bruyère, O, et al.
Izdano: (2014)

Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
od: Bruyere, O, et al.
Izdano: (2012)

Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
od: Bruyere, O, et al.
Izdano: (2013)

STRONTIUM RANELATE INCREASES THE NUMBER OF PATIENTS WITH IMPROVEMENT IN OSTEOARTHRITIS SYMPTOMS COMPARED TO PLACEBO IN THE SEKOIA STUDY
od: Bruyere, O, et al.
Izdano: (2013)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRITIS PROGRESSION: A MRI ANALYSIS
od: Genant, H, et al.
Izdano: (2013)

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate
od: Reginster, J, et al.
Izdano: (2013)

STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRTTIS PROGRESSION
od: Zaim, S, et al.
Izdano: (2013)

STRONTIUM RANELATE DECREASES THE NUMBER OF RAPID RADIOLOGICAL PROGRESSORS FROM THE FIRST YEAR IN SEKOIA STUDY
od: Chevalier, X, et al.
Izdano: (2014)

PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
od: Elena Mikhailovna Zaitseva, et al.
Izdano: (2014-02-01)

STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS
od: Cooper, C, et al.
Izdano: (2013)

STRONTIUM RANELATE PREVENTS SPINE OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH PREVALENT SPINAL OSTEOARTHRITIS
od: O Bruyere, et al.
Izdano: (2007-08-01)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
od: J Y Reginster, et al.
Izdano: (2011-04-01)

STRONTIUM RANELATE: WHAT THE FUTURE HOLDS
od: Cooper, C
Izdano: (2011)

STRONTIUM RANELATE DECREASES VERTEBRAL FRACTURE RISK WHATEVER THE LEVEL OF PRETREATMENT BONE TURNOVER MARKERS
od: J COLLETTE, et al.
Izdano: (2007-08-01)

Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
od: Thiago A. Rodrigues, et al.
Izdano: (2018-09-01)

LONG-TERM BENEFICIAL EFFECTS OF STRONTIUM RANELATE ON THEQUALITY OF LIFE IN PATIENTS WITH VERTEBRAL OSTEOPOROSIS (SOTI STUDY)
od: P MARQUIS, et al.
Izdano: (2007-08-01)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
od: O. A. Nikitinskaya, et al.
Izdano: (2018-09-01)

STRONTIUM RANELATE AND RISK OF VENOUS THROMBOEMBOLISM (VTE): AN UPDATE OF A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
od: Cooper, C, et al.
Izdano: (2012)

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
od: T.A. Rodrigues, et al.
Izdano: (2018-06-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
od: Nataliya Vladimirovna Toroptsova
Izdano: (2010-09-01)

Strontium ranelate is a drug to treat osteoarthrosis
od: Oksana Anatolyevna Nikitinskaya
Izdano: (2013-03-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
od: Nataliya Vladimirovna Toroptsova
Izdano: (2010-09-01)

Strontium ranelate's dual action: A closer look
od: Russell, R
Izdano: (2006)

Bivalos (strontium ranelate) administration experience in postmenopausal osteoporosis
od: I A Skripnikova, et al.
Izdano: (2009-04-01)

Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy
od: N V Toroptsova, et al.
Izdano: (2010-02-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
od: Olga Borisovna Yershova
Izdano: (2010-12-01)

EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF MALE OSTEOPOROSIS
od: J M Kaufman, et al.
Izdano: (2012-08-01)

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
od: Roberto Cesareo, et al.
Izdano: (2009-12-01)

STRONTIUM RANELATE DEMONSTRATES VERTEBRAL AND NON-VERTEBRAL ANTI FRACTURE EFFICACY INCLUDING HIP FRACTURES OVER 5 YEARS IN POST MENOPAUSAL OSTEOPOROTIC WOMEN
od: J Y REGINSTER, et al.
Izdano: (2007-08-01)

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
od: N V Toroptsova, et al.
Izdano: (2008-06-01)